J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, Y.
Right arrow Articles by Tabata, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, Y.
Right arrow Articles by Tabata, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 21, 1090-1096, Copyright © 1980 by Lipid Research, Inc.


ARTICLES

Selective reduction of phosphatidylglycerol and phosphatidylcholine in pulmonary surfactant by 4-aminopyrazolo(3,4d)pyrimidine in the rat

Y Suzuki and R Tabata

Effects of 4-aminopyrazolo(3,4d)pyrimidine on pulmonary surface-active material and its surface activity were investigated in the rat. A rapid decrease in serum cholesterol was observed in rats treated with this drug and these effects continued during the entire period of treatment. Phosphatidylglycerol content in surface-active material and in the residual lung decreased significantly during three days of treatment and phosphtidylcholine content in surface-active material also decreased on the third day of the treatment. There were no changes in the contents of other phospholipids and cholesterol. The surface-active material from treated rats showed a larger surface compressibility, an elevated minimum surface tension, and a low stability index, as compared to control rats. These results show that alteration of lipid constituents significantly affects the surface properties of pulmonary surface-active material and that 4-aminopyrazolopyrimidine is a drug which can be effectively utilized to investigate lipid metabolism of the lung.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. R. Bates, J.-Q. Tao, H. L. Collins, O. L. Francone, and G. H. Rothblat
Pulmonary abnormalities due to ABCA1 deficiency in mice
Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L980 - L989.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1980 by the American Society for Biochemistry and Molecular Biology.